在帕金森病中,肠道衍生乌洛的神经保护性属性
Sushila Chhetry1, Abhideep Roy1, Rubina Roy1
1Department of Life Science and Bioinformatics, Assam University, Silchar, Assam, 788011, India.
Molecular neurobiology
|November 23, 2025
概括
乌罗利是基酸的肠道代谢物,通过减少炎症和氧化应激,在帕金森病 (PD) 中表现有前途. 这些化合物可能通过在PD中准肠-大脑轴功能障碍来提供一种新的治疗策略.
科学领域:
- 微生物组-肠道-大脑轴
- 神经退行性疾病的神经退行性疾病
- 代谢学 代谢学 代谢学
背景情况:
- 帕金森病 (PD) 与肠-大脑轴功能障碍有关,包括失能症和肠道透性增加.
- 乌罗利थिन是食中的基氨酸的代谢物,具有抗氧化,抗炎和增强神经的特性.
- 乌罗利थिन在宿主-微生物群共同代谢和神经保护界面上充当神经调节剂.
研究的目的:
- 在临床前帕金森病模型中审查urolithin生物合成,生物可用性和疗效.
- 探索urolithins作为微生物群衍生干预帕金森病的潜力.
- 合成对乌罗胺神经保护作用的机制性见解.
主要方法:
- 文献综述综合了对urolithin生物合成和生物可用性的机制性见解.
- 临床前帕金森病模型的批判性评估,评估乌洛的疗效.
- 对urolithins对关键帕金森病病原体维度的影响的分析.
主要成果:
- 乌罗利थिन可以保护多巴胺基神经元,并抑制α-synuclein聚合.
- 它们通过激活Nrf2通路来抑制氧化应激,并增强抗氧化防御.
- 乌罗利थिन减轻神经炎症,拯救线粒体功能障碍,并促进自-溶酶体通路.
结论:
- 乌罗利显示出对帕金森病病理学的显著神经保护潜力.
- 它们调节肠道微生物群和宿主新陈代谢的能力提供了一个独特的治疗途径.
- 乌罗利代表了改变帕金森病进展的有希望的微生物群衍生干预措施.
更多相关视频
相关概念视频
01:24Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:37Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
354
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
354
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
343
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
343